Dr Rachel K Morris PhD MRCOG

Dr Rachel K Morris

Institute of Metabolism and Systems Research
Clinical Research Fellow

Contact details

Birmingham Women's Hospital
Metchley Park Road
B15 2TG

Dr Katie Morris is a NIHR Clinical Lecturer in Fetal Medicine. Her research interests include randomised controlled trials in fetal medicine and obstetrics and diagnostic research in the area of fetal growth restriction.


  • PhD Obstetrics and Gynaecology 2011.
  • MRCOG 2003
  • MBChB Hons 1998


Dr Morris is a Subspecialty trainee in Maternal Fetal medicine and holds an NIHR Clinical Lectureship. She has recently been awarded her PhD, funded by an MRC Clinical Research Training Fellowship, examining the accuracy of tests to predict/diagnose fetal growth restriction and compromise of fetal wellbeing combined with decision model analysis and economic analysis.

Her undergraduate education was at the University of Liverpool (MBChB) (qualified 1998). After SHO Obstetrics and Gynaecology training in Leicester, and Registrar posts in Leicester, Lincoln and Boston, she moved to Birmingham Women’s Hospital and Birmingham University as a Clinical Research Fellow in August 2005.


MBChB year 2 and year 5


Dr Morris’ principle interests are:

  • Prediction and prevention of fetal growth restriction and compromise of fetal wellbeing. Systematic reviews and meta-analyses with model-based economic evaluation.
  • PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial.

Research groups that we are collaborating with include Department of General Practice, Academic Medical Center, Amsterdam; Department of Biostatistics, University of Compultense, Madrid; School of Surgical and Reproductive Sciences, University of Newcastle.


Malin GL, Morris RK, Laftah Z, Khan KS. Does umbilical cord pH at birth predict perinatal and long term outcome? A systematic review and meta-analysis to evaluate strength of association. BMJ In press

Morris RK, Malin GL, Khan KS, Kilby MD. Systematic review of the effectiveness of antenatal intervention for the treatment of congenital lower urinary tract obstruction. BJOG 2010;117:382-390.

Malin GL,Morris RK, Khan KS. Mary Crosse Project: Systematic reviews and grading the value of neonatal tests in predicting long term outcomes. BMC Pregnancy and Childbirth 2009, 9:49.

Morris RK, Malin GM, Khan KS, Kilby MD.Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: Systematic review of test accuracy. BJOG2009;116(10) 1290-1299.

Morris R K,Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, Mol BW, van der Post JA, Khan KS. Serum screening with Down's Syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysis. BMC Pregnancy Childbirth 2008 Aug 4;8(1):33. 

Cnossen JS, Morris RK, Mol BWJ, ter Riet G, van der Post JAM, Bindels PJE, Robson S, Kleijnen J, Coomarasamy A, Khan KS. Uterine artery Doppler to predict fetal growth restriction: a systematic review and bivariate meta-analysis. Canadian Medical Association Journal 2008;178(6):701-11.

Morris RK, Quinlan-Jones E, Kilby MD, Khan KS. Systematic review of accuracy of fetal urine analysis to predict postnatal renal function in cases of congenital urinary tract obstruction. Prenatal Diagnosis 2007;27(10):900-11.

Morris RK, Khan KS, Coomarasamy A, Robson SC, Kleijnen J. The value of predicting restriction of fetal growth and compromise of its wellbeing: Systematic quantitative overviews (meta-analysis) of test accuracy literature. BMC Pregnancy and Childbirth 2007, 7:3

PLUTO Collaborative Study Group. PLUTO: The percutaneous shunting for lower urinary tract obstruction trial. British Journal of Obstetrics and Gynaecology 2007;114(7): 904-905.